(Q34612112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Rachel F Tyndale

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Lisa A Howard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

185-199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

Genetic variability in susceptibility and response to toxicants

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Cytochrome P450 and the individuality of species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Pharmacokinetic Determinants of Drug Abuse and Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Science, medicine, and the future: Pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Mimicking gene defects to treat drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Genetic and environmental contributions to smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Tobacco consumption in Swedish twins reared apart and reared together

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Nicotine blood levels and subjective craving for cigarettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Smoking behaviour and compensation: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Nicotine metabolism defect reduces smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Massive dextromethorphan ingestion and abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Neurobiology of opiate abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Differences in diazepam pharmacokinetics in Chinese and white Caucasians--relation to body lipid stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Racial, ethnic and gender differences in response to medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Mechanisms of ethanol-drug-nutrition interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The effects of the ALDH2*1/2, CYP2E1 C1/C2 and C/D genotypes on blood ethanol elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Alcoholism among women: a comparison of Black and White problem drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Genome polymorphism and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Smoking and peripheral vascular disease. Epidemiology and podiatric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

DNA adduct formation from tobacco-specific N-nitrosamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Inhibition of cytochrome P450 2D6 modifies codeine abuse liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Cytochrome P450 2D6 and treatment of codeine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Transcriptional control of the rat hepatic CYP2E1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Role of the liver-enriched transcription factor HNF-1 alpha in expression of the CYP2E1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Drug-activation of brain reward pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Polymorphisms in genes involved in neurotransmission in relation to smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

CLINICAL CORRELATES OF CIGARETTE SMOKING AND NICOTINE DEPENDENCE IN ALCOHOL-DEPENDENT MEN AND WOMEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.2.185

21 January 2018

Identifiers

DOI

10.1517/14622416.3.2.185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11972441%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference